Toby Cosgrove, former CEO of Cleveland Clinic and Kyle Kiser, CEO of Arrive Health, discuss changes in healthcare, aiming to improve patient affordability. Rising drug costs and lack of cost transparency are significant barriers to treatment compliance. In 2022, the Robert Wood Johnson Foundation and Urban Institute found that an estimated 13 million adults either didn’t fill a prescription or delayed it due to high costs. Dr. Cosgrove and Kyle discuss real-world opportunities to bring cost relief to patients in need.
This episode is sponsored by Arrive Health.
